Monthly Archives: May 2013

Cannabis Induces a Clinical Response in Patients with Crohn’s Disease

Although the primary endpoint of the study (induction of remission) was not achieved, a short course (8 week) of THC-rich cannabis produced significant clinical, steroid-free benefits to 11 patients with active CD, compared to placebo, without side effects.

Posted in Uncategorized | Tagged | Leave a comment

Biologic Agents Might Cause Acute Liver Injury

Of the TNF-α antagonists, infliximab-associated liver injury has been the best documented, most likely because of its earlier approval and more wide-spread clinical use. Etanercept and adalimumab have also been linked to drug-induced liver injury. So far, there are no … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment